Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience

Objectives To evaluate and categorize the survival benefit of tricyclic antidepressants (TCAs) in lung cancer patients based on systematic computational drug repositioning data. Methods Data were retrospectively extracted from the medical records of non-small cell lung cancer (NSCLC) patients from t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nagla Fawzy Abdel Karim, Rammey Hassan, Nabeela Iffat Siddiqi, Ihab Eldessouki, Ola Gaber, Mohamed Rahouma, Mohamed Kamel, Mhender Yellu, Shuchi Gulati, Changchun Xie, Mohamed Magdy, Jane Pruemer
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2019-12-01
Col·lecció:	Journal of International Medical Research
Accés en línia:	https://doi.org/10.1177/0300060519862469
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!